Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
Vishnu Priya Pulipati, Founder and Host of LipidCurious Podcast, Member of Institutional Review Ethics Board at Saint Francis Health System, shared on LinkedIn:
”Let’s talk about statins. I know… boring, right?
Most of us already know a lot about them.
But thinking of statins only as cholesterol drugs misses the bigger picture.
In many ways, statins are best understood as Anti-atherosclerotic therapies that modify plaque biology, vascular inflammation, and cardiovascular risk far beyond simple LDL reduction.
In this episode, we cover:
- Pleiotropic effects of statins beyond LDL-C lowering
- Choosing the right statin in special populations
- Why statins remain foundational therapy even in the era of newer lipid-lowering drugs
Bonus: Visual guide to help you navigate the episode.
Free CME/CE available for listening.
Listen at www.lipidcurious.com, Apple Podcasts, Spotify, or YouTube Podcasts.
Want a companion resource? Download the free LipidCurious Starter Kit.
Questions or feedback? [email protected]
Disclaimer: Educational content only. Not medical advice.
Clinicians should use independent clinical judgment and applicable guidelines.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 21:27Satish Bondala: Blood Bank and Transfusion Services – The Lifeline of Hospitals
-
Apr 15, 2026, 21:26Tareq Abadl: Understanding Thalassemia – Breaking the ‘Ordinary Anemia’ Myth
-
Apr 15, 2026, 21:24Wolfgang Miesbach: Key Message from John Semple on Platelets as Immune Cells in ITP
-
Apr 15, 2026, 21:22Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
-
Apr 15, 2026, 18:45Elias Lee: Acute PE from Subclavian VT – CT Scan Diagnosis, Radiology Interpretation, and Emergency Imaging Insights
-
Apr 15, 2026, 17:30Rivaroxaban versus Aspirin after Atrial Fibrillation Ablation – Cardiology Insights and Heart Health
-
Apr 15, 2026, 17:01Emmanuel J Favaloro: A Practical Approach to Inherited and Acquired Coagulation Disorders
-
Apr 15, 2026, 16:55Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events – Key Clinical Pearls
-
Apr 15, 2026, 16:54Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory